NCT05335941
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Cancer, +8 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Metastatic Cancer
Explore clinical trials studying Metastatic Cancer. Study availability and eligibility vary by location and protocol.
430 public trials
83 recruiting studies
Metastatic Cancer trial results
Active, Not Recruiting
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer
NCT03794635
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genitourinary Cancer, +20 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
NCT02756793
- Conditions
- Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Alberta Health Services-Cross Cancer Institute Edmonton, Alberta, Canada
- BC Cancer - Prince George Prince George, British Columbia, Canada
- BC Cancer Fraser Valley Centre Surrey, British Columbia, Canada
- BC Cancer Agency Branch Vancouver, British Columbia, Canada
Active, Not Recruiting
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
NCT05566574
- Conditions
- Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center at Suffolk-Commack (All Protocol Activities) Commack, New York, United States
Active, Not Recruiting
Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer
NCT05032092
- Conditions
- Locally Advanced Carcinoma, Metastatic Cancer, Neoplasm Metastasis, +4 more
- Locations
-
- University Hospital Salzburg, Department of Internal Medicine III Salzburg, State of Salzburg, Austria
- Medical University of Innsbruck, Department of Hematology and Oncology Innsbruck, Tyrol, Austria
- Ordensklinikum Linz Linz, Upper Austria, Austria
- Landeskrankenhaus Feldkirch, Department of Internal Medicine II Feldkirch, Vorarlberg, Austria
Active, Not Recruiting
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
NCT02293954
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +59 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
NCT03785249
- Conditions
- Advanced Cancer, Colonic Diseases, Colonic Neoplasms, +20 more
- Locations
-
- Local Institution - 001-826 Birmingham, Alabama, United States
- Local Institution - 001-965 Anchorage, Alaska, United States
- Local Institution - 001-821 Phoenix, Arizona, United States
- Local Institution - 001-873-A Tucson, Arizona, United States
Active, Not Recruiting
HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)
NCT04257162
- Conditions
- Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- ICO Badalona Badalona, Barcelona, Spain
- Hospital del Mar Barcelona, Spain
- Hospital Clínic de Barcelona Barcelona, Spain
- Hospital Universitario de Jerez Jerez de la Frontera, Cadiz, Spain
Active, Not Recruiting
Biomarkers of Immune-Related Toxicity
NCT03409016
- Conditions
- Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
Active, Not Recruiting
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
NCT05669482
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +14 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- University of Chicago Chicago, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Cancer Center Ann Arbor, Michigan, United States